A cohort of supporting metabolic enzymes is coinduced with nitric oxide synthase in human tumor cell lines

Cancer Letters

Volumn 103, Issue 1, 1996, Pages 79-84

  Nussler, Andreas K ^a   Liu, Zhi Ze ^b   Hatakeyama, Kazuyuki ^b   Geller, David A ^b   Billiar, Timothy R ^b   Morris Jr , Sidney M ^c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Arginine; Cytokines; Human tumor; Nitric oxide

Indexed keywords

ARGININE; ARGININOSUCCINATE SYNTHASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TETRAHYDROBIOPTERIN;

ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029866048     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04199-7     Document Type: Article

References (24)

1. Morris, Jr., S.M. and Billiar, T.R. (1994) New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol., 266, E829-E839.
2. Nussler, A.K. and Billiar, T.R. (1993) Inflammation, immunoregulation and inducible nitric oxide synthase. J. Leukoc. Biol., 54, 171-178.
3. Harbrecht, B.G. and Billiar, T.R. (1995) The role of nitric oxide in Kupffer cell-hepatocyte interactions. Shock, 3, 79-87.
4. Sherman, P.A., Laubach, V.E., Reep, B.R. and Wood, E.R. (1993) Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry, 32, 11600-11605.
5. Jenkins, D.C., Charles, I.G., Baylis, S.A., Lelchuk, R., Radomski, M.W. and Moncada, S. (1994) Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br. J. Cancer, 70, 847-849.
6. Chu, S.C., Wu, H.-P., Banks, T.C., Eissa, N.T. and Moss, J. (1995) Structural diversity in the 5′-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J. Biol. Chem., 270, 10625-10630.
7. Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G. and Moncada, S. (1995) Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72, 41-44.
8. Ochoa, J.B., Curti, B., Peitzman, A.B., Simmons, R.L., Billiar, T.R., Hoffman, R., Rault, R., Longo, D.L., Urba, W.J. and Ochoa, A.C. (1992) Increased circulating nitrogen oxides after human tumor immunotherapy correlate with toxic hemodynamic changes. J. Natl. Cancer Inst., 84, 864-867.
9. Hibbs, Jr., J.B., Westenfelder, C., Taintor, R.R., Vavrin, Z., Kablitz, C., Baranowski, R.L., Ward, J.H., Menlove, R.L., McMurry, M.P., Kushner, J.P. and Samlowski, W.E. (1992) Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest., 89, 867-877.
10. Andrade, S.P., Hart, I.R. and Piper, P.J. (1992) Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br. J. Pharmacol., 107, 1092-1095.
11. Buttery, L., Springall, D., Andrade, S., Riveros-Monero, V., Hart, I., Piper, P.J. and Polak, J.M. (1993) Induction of nitric oxide synthase in the neovasculature of experimental tumors in mice. J. Pathol., 171, 311-319.
12. Maeda, H., Noguchi, Y., Sato, K. and Akaike, T. (1994) Enhanced vascular permeability in solid tumors is mediated by nitric oxide and inhibited by both new nitric oxide scavengers and nitric oxide synthase inhibitor. Jpn. J. Cancer Res., 85, 331-334.
13. Nussler, A.K., Billiar, T.R., Liu, Z.-Z. and Morris, Jr., S.M. (1994) Coinduction of nitric oxide synthase and argininosuccinate synthetase in a marine macrophage cell line. J. Biol. Chem., 269, 1257-1261.
14. Hattori, Y., Campbell, E.B. and Gross, S.S. (1994) Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. J. Biol. Chem., 269, 9405-9408.
15. Flodstrom, M., Niemann, A., Bedoya, F.J., Morris, Jr., S.M. and Eizirik, D.L. (1995) Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic β-cells: induction of argininosuccinate synthetase by cytokines. Endocrinology, 136, 3200-3206.
16. Werner-Felmayer, G., Werner, E.R., Fuchs, D., Hausen, A., Reibnegger, G. and Wachter, H. (1990) Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J. Exp. Med., 172, 1599-1606.
17. Isom, H.C. and Geroff, I. (1984) Quantitative assay for albumin-producing liver cells after simian virus 40 transformation of rat hepatocytes maintained in chemically defined medium. Proc. Natl. Acad. Sci. USA, 81, 6378-6382.
18. Hatakeyama, K., Harada, T., Suzuki, S., Watanabe, Y. and Kagamiyama, H. (1989) Purification and characterization of rat liver GTP cyclohydrolase I. J. Biol. Chem., 264, 21660-21664.
19. Geller, D.A., Lowenstein, C.J., Shapiro, R.A., Nussler, A.K., Di Silvio, M., Wang, S.C., Nakayama, O.K., Simmons, R.L., Snyder, S.H. and Billiar, T.R. (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA, 90, 3491-3495.
20. Hatakeyama, K., Inoue, Y., Harada, T. and Kagamiyama, H. (1991) Cloning and sequencing of cDNA encoding rat GTP cyclohydrolase I. The first enzyme of the tetrahydrobiopterin biosynthetic pathway. J. Biol. Chem., 266, 765-769.
21. Nussler, A.K., Di Silvio, M., Liu, Z.-Z., Geller, D.A., Freeswick, P., Dorko, K., Bartoli, F. and Billiar, T.R. (1995) Further characterization and comparison of inducible nitric oxide synthase in mouse, rat and human hepatocytes. Hepatology, 21, 1552-1560.
22. Thomsen, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.E., Riveros-Moreno, V. and Moncada, S. (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54, 1352-1354.
23. Jenkins, D.C., Charles, I.G., Thomsen, L.L., Moss, D.W., Holmes, L.S., Baylis, S.A., Rhodes, P., Westmore, K., Emson, P.C. and Moncada, S. (1995) Role of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92, 4392-4396.
24. Xie, K., Huang, S., Dong, Z., Juang, S.-H., Gutman, M., Xie, X., Nathan, C. and Fidler, I.J. (1995) Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med., 181, 1333-1343.